Skip to content

Clinical trials

Respiratory Tract Neoplasms trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Neoplasms Country / region: Italy Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20121
20141
20151
20161
20173
20191
20201
20211
20221
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting4
Active, not recruiting3
Completed3
Terminated3
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
Revolution Medicines, Inc.3
Hoffmann-La Roche2
ArriVent BioPharma, Inc.1
Daiichi Sankyo1
Federico II University1
Turning Point Therapeutics, Inc.1
University of Turin, Italy1
sigma-tau i.f.r. S.p.A.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Tract Neoplasms15
Lung Neoplasms13
Carcinoma, Non-Small-Cell Lung12
Lung Diseases12
Respiratory Tract Diseases12
Bronchial Neoplasms11
Neoplasms11
Thoracic Neoplasms11
Neoplasms by Site10
Carcinoma, Bronchogenic7

Trials

Showing 26 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.